102

Bridging the Gap: Nurses Leading the Fight for Alzheimer's Health Equity

In honor of Black History Month, this episode of BrainStorm by UsAgainstAlzheimer’s explores the critical intersection of Alzheimer's disease and health equity in African-American communities

LISTEN NOW
January 27, 2026

One Million Visitors and the Power of Early Detection

Reaching one million visitors is more than a milestone for BrainGuide. It is proof that trusted, accessible information can make a real difference in people’s lives. Behind every visit is a person seeking answers about brain health. Someone noticing changes. Someone caring for a loved one. Someone taking a first or next step during a moment of uncertainty. We’re honored to have supported one million people, families, concerned individuals -- and counting -- who turned to BrainGuide for answers. Since its launch in 2021, BrainGuide has supported people in learning about brain health, recognizing when changes may matter, and feeling
101

The Marriage Sabbatical - Finding Love and Living with MCI with Leah Fisher

This episode of BrainStorm, by UsAgainstAlzheimer’s, features host Meryl Comer interviewing Leah Fisher, a psychotherapist and author who took a bold year-long solo travel sabbatical at age 60 to explore different cultures while maintaining her marriage.
LISTEN NOW
January 20, 2026

Congress Increases Funding for Alzheimer’s Disease and Other Dementia Research

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
November 24, 2025

UsAgainstAlzheimer’s Statement on Initial Findings from Novo Nordisk Alzheimer’s EVOKE and EVOKE+ Trials

98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW
November 13, 2025

Alzheimer’s Awareness Month Blog | 
Fact vs. Fiction: Why Early Detection of Alzheimer’s Matters

Alzheimer’s Awareness Month Blog
Fact vs. Fiction: Why Early Detection of Alzheimer’s Matters This Alzheimer’s Awareness Month brings both reflection and hope. The FDA’s recent approval of the first blood test that can help primary care providers rule out Alzheimer’s marks another step forward in how we understand and detect this disease. 
 This milestone reinforces a critical truth: early detection matters. Alzheimer’s begins years—even decades—before noticeable symptoms appear. The sooner we recognize and understand what’s happening in the brain, the more options people have to take control of their health, plan for the future, and participate in research that can
November 6, 2025

UsAgainstAlzheimer's Campaign to Increase Early Alzheimer's Detection in Latino Communities Enters Final Week in El Paso and Phoenix